Clinical Trial Update: Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of NH004 Films for relief of sialorrhea in Parkinson's disease patients completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• NH004 Films

Snippet

Sponsor: NeuroHealing Pharmaceuticals Inc. | Conditions: Sialorrhea Secondary to Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-10-12